Health ❯ Healthcare ❯ Chronic Conditions

Type 2 Diabetes

Management Strategies Weight Management Treatment Options GLP-1 Medications Medication Management Weight Loss Medications Monitoring and Management Obesity Hypertension Insulin Sensitivity

FDA Approves Awiqli, First Once-Weekly Basal Insulin for Type 2 Diabetes

The weekly shot could improve adherence by replacing daily injections with one dose.

Heart Risks Rebound After GLP-1 Breaks, New Data Show Continuous Use Is Safest

Vanderbilt Study Maps 70 Conditions That Precede Alzheimer’s by a Decade

UK Regulator Adds Severe Pancreatitis Warning to Ozempic, Wegovy and Mounjaro

Novo Nordisk Files FDA Application for Weekly CagriSema Obesity Shot as GLP-1 Competition Intensifies

Lilly Taps Walmart for First Retail Pickup of Discounted Zepbound Vials Starting Mid-November

EMA Approves Cardiovascular Indication for Novo Nordisk’s Rybelsus

NHS Orders 55,000 Diabetes Retests After Faulty Lab Machines Trigger False Results

UK Regulator Probes Pancreatitis Cases Tied to GLP-1 Weight-Loss Therapies

Novo Nordisk’s Amycretin Delivers Up to 24% Early Weight Loss in Dual-Form Trials

NHS Weight-Loss Jab Prescriptions Near Three Million as Experts Raise Lifelong Use Concerns

Scotland Faces Health Crisis Linked to Weight-Loss Injections

Pharmacists Warn Against Fake Weight-Loss Jabs Amid Ozempic Shortage

FDA Issues Warning on Overdoses from Compounded Semaglutide Injections